Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10280
Gene Symbol: SIGMAR1
SIGMAR1
0.120 GeneticVariation phenotype BEFREE SIGMAR1 mutation should be included in the diagnostic panel of a dHMN, especially if there are co-existing pyramidal signs and autosomal recessive inheritance. 29115704 2018
Entrez Id: 10280
Gene Symbol: SIGMAR1
SIGMAR1
0.120 GeneticVariation phenotype BEFREE We suggest that coding sequence mutations in SIGMAR1 present clinically with a combination of dHMN and pyramidal tract signs, with or without spasticity, in the lower limbs. 27629094 2016
Entrez Id: 23064
Gene Symbol: SETX
SETX
0.120 Biomarker phenotype BEFREE These data suggest that ALS4 and distal hereditary motor neuronopathy with pyramidal tract signs may be one and the same disorder. 12023320 2002
Entrez Id: 23064
Gene Symbol: SETX
SETX
0.120 GeneticVariation phenotype BEFREE Pyramidal signs and dystonia were more frequent and disease was less severe with missense mutations in the helicase domain of senataxin gene than with missense mutations out of helicase domain and deletion and nonsense mutations (P = 0.001, P = 0.008 and P = 0.01, respectively). 19696032 2009
Entrez Id: 26580
Gene Symbol: BSCL2
BSCL2
0.110 GeneticVariation phenotype BEFREE BSCL2 gene mutations are associated with a wide spectrum of clinical and electrophysiological phenotypes and should be suspected in cases of distal hereditary motor neuropathy with pyramidal signs or early hand involvement. 25454168 2015
Entrez Id: 1593
Gene Symbol: CYP27A1
CYP27A1
0.110 GeneticVariation phenotype BEFREE The most predominant mutations in CYP27A1 were c.410G > A and c.379C > T, and the most common clinical manifestations were pyramidal signs, xanthomatosis, cerebellar ataxia, and cognitive impairment. 31796091 2019
Entrez Id: 4001
Gene Symbol: LMNB1
LMNB1
0.110 GeneticVariation phenotype BEFREE Duplication of the LMNB1 gene encoding lamin B1 causes adult-onset autosomal-dominant leukodystrophy (ADLD) starting with autonomic symptoms, which are followed by pyramidal signs and ataxia. 26053668 2015
Entrez Id: 25793
Gene Symbol: FBXO7
FBXO7
0.040 GeneticVariation phenotype BEFREE Mutations in the FBXO7 gene cause an autosomal-recessive early-onset parkinsonism with pyramidal tract signs. 23352116 2013
Entrez Id: 25793
Gene Symbol: FBXO7
FBXO7
0.040 GeneticVariation phenotype BEFREE Mutations in several autosomal genes, including the F-box only protein 7 (FBXO7) gene, have been found in patients suffering from juvenile-onset parkinsonism with pyramidal signs. 29174172 2018
Entrez Id: 25793
Gene Symbol: FBXO7
FBXO7
0.040 GeneticVariation phenotype BEFREE Mutations in FBXO7 (PARK15) have been associated with a syndrome characterized by early-onset progressive parkinsonism with and without pyramidal tract signs. 24112787 2014
Entrez Id: 25793
Gene Symbol: FBXO7
FBXO7
0.040 GeneticVariation phenotype BEFREE The F-box protein 7 (FBXO7) mutations have been identified in families with early-onset parkinsonism and pyramidal tract signs, and designated as PARK15. 27765362 2016
Entrez Id: 3798
Gene Symbol: KIF5A
KIF5A
0.010 Biomarker phenotype BEFREE Another 66 patients with HSP or CMT2 with pyramidal signs were sequenced for all exons of KIF5A by targeted resequencing. 25008398 2014
Entrez Id: 339453
Gene Symbol: TMEM240
TMEM240
0.010 GeneticVariation phenotype BEFREE A systematic review of all previously reported SCA21 patients (n = 42) demonstrates that SCA21 is a relatively early-onset SCA (median onset age 18 years; range 1-61 years) with frequent non-cerebellar involvement, including hyporeflexia (69%), bradykinesia (65%), slow saccades (38%) and pyramidal signs (17%). 30522958 2019
Entrez Id: 6305
Gene Symbol: SBF1
SBF1
0.010 Biomarker phenotype BEFREE The novel SBF1 null mutation highlights distinct severe phenotypic manifestations, broadening the clinical spectrum of SBF1-related neuropathies: cerebellar and pyramidal signs evident in the first months of life with peripheral polyneuropathy emerging only toward the end of the first decade, together with unique MRI findings. 30039846 2018
Entrez Id: 3295
Gene Symbol: HSD17B4
HSD17B4
0.010 Biomarker phenotype BEFREE Genetic analysis of HSD17B4 should be considered in adult patients with cerebellar ataxia, peripheral neuropathy, and pyramidal signs in addition to sensorineural auditory disturbance since childhood. 28017249 2017
Entrez Id: 6712
Gene Symbol: SPTBN2
SPTBN2
0.010 Biomarker phenotype BEFREE To date, only two other SPTBN2 mutations with recessive pattern of inheritance causing SCAR14 (spinocerebellar ataxia, autosomal recessive 14) that manifest with developmental ataxia and cognitive impairment, or cerebellar ataxia, mental retardation, and pyramidal signs have been reported. 28636205 2017
Entrez Id: 7173
Gene Symbol: TPO
TPO
0.010 Biomarker phenotype BEFREE MSA is an adult-onset, sporadic, progressive parkinsonian syndrome characterised by the presence of akinesia, cerebellar dysfunction, autonomic failure and pyramidal signs. 30704970 2019
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.010 Biomarker phenotype BEFREE Larger expansions correlated with areflexia in SCA 2, with pyramidal signs in SCA 3 and with early visual impairment in SCA 7. 15876341 2005
Entrez Id: 23095
Gene Symbol: KIF1B
KIF1B
0.010 GeneticVariation phenotype BEFREE Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. 20806400 2010
Entrez Id: 83636
Gene Symbol: C19orf12
C19orf12
0.010 GeneticVariation phenotype BEFREE Patients from 13 different families having progressive motor symptoms with irritative pyramidal signs and brain iron accumulation were screened for C19orf12 gene variants. 31804703 2019
Entrez Id: 4976
Gene Symbol: OPA1
OPA1
0.010 GeneticVariation phenotype BEFREE Human skin fibroblasts were isolated from a 48-year-old patient carrying compound heterozygous mutations (c.610+364G>A and c.1311A>G) in OPA1, responsible for early onset optic atrophy complicated by ataxia and pyramidal signs (Behr syndrome; OMIM #210000). 27879217 2016
Entrez Id: 25894
Gene Symbol: PLEKHG4
PLEKHG4
0.010 GeneticVariation phenotype BEFREE The locus was exactly the candidate interval of SCA4, a rare form of ADCA clinically characterized by ataxia with sensory neuropathy and pyramidal tract signs. 10822439 2000
Entrez Id: 22880
Gene Symbol: MORC2
MORC2
0.010 GeneticVariation phenotype BEFREE MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs. 26659848 2016
Entrez Id: 3708
Gene Symbol: ITPR1
ITPR1
0.010 Biomarker phenotype BEFREE Clinical data of ten patients and brain MRI (available for six) showed that the phenotype substantially overlapped known SCA15 cases,but we also noted buccolingual dyskinesias, facial myokymias,and pyramidal signs never reported in SCA15. 20082166 2010
Entrez Id: 3316
Gene Symbol: HSPB2
HSPB2
0.010 Biomarker phenotype BEFREE Atypical features such as deafness and pyramidal signs were present in our cases adding new data to the large spectrum of HSP27-related phenotype. 25547330 2015